Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light

Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products

(2010) Raymond P. Goodrich et al.   BIOLOGICALS

Transfusion-transmitted diseases: risks, prevention and perspectives

(2010) Anne C. E. Moor et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

In vitro cell quality of buffy coat platelets in additive solution treated with pathogen reduction technology

(2010) Sisse R. Ostrowski et al.   TRANSFUSION

White blood cell inactivation after treatment with riboflavin and ultraviolet light

(2010) Susanne Marschner et al.   TRANSFUSION

Defining “adequate” pathogen reduction performance for transfused blood components

(2010) Raymond P. Goodrich et al.   TRANSFUSION

The cost-effectiveness of pathogen reduction technology as assessed using a multiple risk reduction model

(2010) Brian Custer et al.   TRANSFUSION

Annexin V Release and Transmembrane Mitochondrial Potential during Storage of Apheresis-Derived Platelets Treated for Pathogen Reduction

(2010) Susanne M. Picker et al.   TRANSFUSION MEDICINE AND HEMOTHERAPY

Pathogen reduction of fresh plasma using riboflavin and ultraviolet light: effects on plasma coagulation proteins

(2009) Valerie S. Hornsey et al.   TRANSFUSION

Cell viability during platelet storage in correlation to cellular metabolism after different pathogen reduction technologies

(2009) Susanne M. Picker et al.   TRANSFUSION

BLOOD COMPONENTS: Lack of antibody formation to platelet neoantigens after transfusion of riboflavin and ultraviolet light-treated platelet concentrates

(2009) Daniel R. Ambruso et al.   TRANSFUSION

A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns

(2009) Raymond P. Goodrich et al.   TRANSFUSION

Platelet function assessed by shear-induced deposition of split triple-dose apheresis concentrates treated with pathogen reduction technologies

(2009) Susanne M. Picker et al.   TRANSFUSION

Evaluation of the Mirasol platelet reduction technology system against Babesia microti in apheresis platelets and plasma

(2009) Laura Tonnetti et al.   TRANSFUSION

Protein quality in Mirasol pathogen reduction technology-treated, apheresis-derived fresh-frozen plasma

(2009) James Smith et al.   TRANSFUSION

Cell integrity and mitochondrial function after Mirasol-PRT treatment for pathogen reduction of apheresis-derived platelets: Results of a three-arm in vitro study

(2009) Susanne M. Picker et al.   TRANSFUSION AND APHERESIS SCIENCE

The influence of riboflavin photochemistry on plasma coagulation factors

(2009) Luis Larrea et al.   TRANSFUSION AND APHERESIS SCIENCE

Properties of Pathogen-Inactivated Plasma Components

(2009) Christopher Prowse   TRANSFUSION MEDICINE REVIEWS

Functional characteristics of apheresis-derived platelets treated with ultraviolet light combined with either amotosalen-HCl (S-59) or riboflavin (vitamin B2) for pathogen-reduction

(2009) S. M. Picker et al.   VOX SANGUINIS

Mirasol Pathogen Reduction Technology®treatment does not affect acute lung injury in a two-event in vivo model caused by stored blood components

(2009) C. C. Silliman et al.   VOX SANGUINIS

Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at −30°C

(2009) D. J. Bihm et al.   VOX SANGUINIS

Effects of Mirasol PRT treatment on storage lesion development in plasma-stored apheresis-derived platelets compared to untreated and irradiated units

(2008) Susanne M. Picker et al.   TRANSFUSION

Evaluation of potential immune response and in vivo survival of riboflavin-ultraviolet light-treated red blood cells in baboons

(2008) Raymond P. Goodrich et al.   TRANSFUSION

Pathogen Reduction: A Precautionary Principle Paradigm

(2008) Harvey J. Alter   TRANSFUSION MEDICINE REVIEWS

Toxicity Testing of a Novel Riboflavin-Based Technology for Pathogen Reduction and White Blood Cell Inactivation

(2008) Heather L. Reddy et al.   TRANSFUSION MEDICINE REVIEWS